Acqumen Medical, Inc.
Golden Valley, MN
- UEI
- ZQJFTHZ1WSW7
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 8085 Wayzata Blvd #103, Golden Valley, MN 55426, USA
- Website
- acqumenmedical.com
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Children's Research Institute | P50FD007965 | $50,000 | |
| The Regents Of The University Of California. San Francisco | P50FD007967 | $50,000 | |
| The Regents Of The University Of California. San Francisco | P50FD007967 | $50,000 |
About the company
Acqumen Medical, Inc., a for-profit medical device development firm based in Golden Valley, Minnesota, operates exclusively as a sub-recipient on federal research grants, with no prime contracting footprint in the source data. The vendor has received three federal grant sub-awards totaling $150 thousand in obligated dollars across a two-year span (2025–2026), all funded by the Department of Health and Human Services' Food and Drug Administration.
Acqumen Medical's recent work centers on pediatric ultrasound technology development and algorithm validation. Under a sub-award from The Regents of the University of California, San Francisco (awarded April 10, 2025), the vendor performed bench testing and simulation modeling of a fully integrated ultrasound system, delivering written results and white-paper documentation by August 31, 2025. In a second sub-award from the same prime (awarded December 4, 2025), Acqumen Medical advanced an ultrasound technology platform called UltraTrac, completing a preliminary design update and building a prototype for bench testing by February 28, 2026, while developing regulatory strategy and reimbursement documentation through June 30, 2026. A third sub-award from the Children's Research Institute (awarded June 26, 2026) places Acqumen Medical within the Alliance for Pediatric Device Innovation program. All three awards appear to funnel through FDA-regulated pediatric medical device pathways, with explicit deliverables tied to prototype development, regulatory pre-submission documentation, and commercialization strategy.
Activity is light and emerging — two awards in 2025, one in 2026 — with no visible recompete cliff or vehicle positioning. The vendor has not competed for prime contracts or IDV seats in the source window. Acqumen Medical's role is narrow: sub-recipient technical contributor on university-led and research-institute-led pediatric device projects, with emphasis on ultrasound systems engineering, algorithm development, and regulatory-pathway support.
Quick answers
Is Acqumen Medical, Inc. registered in SAM.gov?
Yes. Acqumen Medical, Inc.'s SAM.gov registration is active through May 1, 2027.
On GovTribe
See Acqumen Medical, Inc.'s full federal record
- Similar vendors